GlobalData on MSN7d
Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS treatment
Dewpoint Therapeutics CEO Ameet Nathwani stated: “This partnership underscores the transformative potential of our small ...
FierceBiotech8d
Mitsubishi Tanabe inks $480M biobucks pact with Dewpoint for preclinical ALS program
Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...
BioPharma Dive8d
Dewpoint, Mitsubishi partner on ALS drug in deal worth up to $480M
The collaboration is another vote of confidence in Dewpoint’s biomolecular condensates research, which had already attracted ...
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS
Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to ...
Outsourcing-pharma7d
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
BioWorld5d
Dewpoint and Mitsubishi ink $480M ALS research collaboration
Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
The Victoria Advocate8d
Mitsubishi Tanabe Pharma America to Present Data on Investigational ND0612 at the 2024 Annual Meeting of the Parkinson Study Group
JERSEY CITY, N.J., Dec. 4, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of two abstracts on investigational ND0612 in Parkinson's disease (PD ...
The Pharma Letter8d
Dewpoint and Mitsubishi Tanabe to advance small molecule condensate modulator for ALS
Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...
Pharmabiz8d
Ainos inks MoU with Taiwan Tanabe Seiyaku to advance manufacturing and Taiwan market promotion of Sjögren's syndrome drug, Veldona
Ainos inks MoU with Taiwan Tanabe Seiyaku to advance manufacturing and Taiwan market promotion of Sjögren's syndrome drug, Veldona: San Diego, California Wednesday, December 4, 2 ...
manilatimes8d
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS
Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to address the underlying pathology of 97% of ALS patients - Mitsubishi Tanabe ...